Summary of Research Findings

Research on Physiological Effects (continued)
4-supplemented rabbits. The mechanism of action may be prevention of lipid and protein oxidation by MAK-4.
Study 1 Research Highlights
Wanatabe Heritable Hyperlipidemic rabbits fed MAK-4 for 6 months showed significantly increased glutathione
peroxidase activity, mean corpuscular hemoglobin concentration and superoxide dismutase, as
compared with the control group. These findings suggest prevention of organ damage in the MAK-4 supplemented
rabbits, which may be due to prevention of lipid and protein oxidation by MAK-4.
2. Title
Subjective Survey, Blood Chemistry and Complete Blood Profile of Subjects Taking Maharishi Amrit Kalash
(MAK)
Publication
Federation of the American Societies for Experimental Biology Journal, Vol. 5, No. 5, p. A1317, 1991 (Abstract).
Authors
K.S. Blasdell,* H.M. Sharma,** P.F. Tomlinson, Jr.,* and R.K. Wallace.*
Conducted at
**Maharishi International University, Fairfield, IA 52556
**Ohio State University, Columbus, OH 43210
Summary
Psychophysiological changes are reported in subjects regularly taking MAK (MAPI, Inc., Lancaster, MA), an
herbal food supplement demonstrating antineoplastic, antioxidant and anti-aging activities in animal and in invitro
studies. Six hundred fifty-nine subjects (age 41+9, taking MAK 22+11 mos) reported substantial benefits
in 19 psychophysiological indices, e.g., increased resistance to illness 87%; happiness 84%; energy 78%; tranquility
83%; mental clarity and emotional balance 80%. Remaining subjects noted no change or condition worsened,
< 1%. A substantial percentage of previous sufferers (46 on medical treatment) reported benefits on 21
illnesses, e.g. colds 94% improved or eliminated, n=209; PMS 84%, 120; constipation 87%, 245; hay fever 81%,
118; headaches 78%, 148; fatigue 88%, 249; asthma 82%, 28; cancer 90%, 10; rheumatoid arthritis 73%, 22; autoimmunity
100%, 10. Only 3% (n=22) reported minor complaints, e.g. bad taste; sugar rush; upset stomach; and
diarrhea. Blood chemistry (24 values) and complete blood profile in 82 separate volunteers showed no abnormal
findings associated with MAK intake. Substantial benefits indicate that MAK may be valuable as a preventive
agent, a therapeutic adjunct and a safe candidate for clinical trials.
Study 2 Research Highlights
Data from 659 human subjects showed that regularly taking MAK carried substantial benefits in 19 psychophysiological
indices and on 21 illnesses, with no abnormal effects, as evaluated by blood chemistry and
complete blood profiles. Therefore, MAK may be valuable as a preventive agent, a therapeutic adjunct and a
safe candidate for clinical trials.
78